← All stocks

Surrozen, Inc./DE

SRZN Net buying
CIK 0001824893 #3678 in the set updated 17 Sep 2026
Bought (120 mo)
$34.85M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$7.27M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$7.27M
13 of 13 sales
Net
+$27.58M
+$27.58M against sales at will

By person

16 insiders · 89 transactions
0.6×

Craig Parker holds only 0.6 times base salary in stock. $386.22K of shares against $630.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Craig Parker last reported holding, valued at $21.25, the price Common Stock was last bought or sold at on the open market here, on 22 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
COLUMN GROUP III GP, LP entity
10% owner
$20.98M (23)
+$20.98M
1,016,658
$21.60M
Kutzkey Tim
Director
$8.98M (20)
+$8.98M
1,016,658
$21.60M
+150.5%
TCG Crossover GP II, LLC entity
10% owner
$4.88M (20)
$6.91M (2)
−$2.03M
574,047
$12.20M
−18.0%
Parker Craig C
Chief Executive Officer
(1)
$150.80K (1)
−$150.80K
18,175
$386.22K
Williams Charles O
Chief Operating Officer
(1)
$119.49K (3)
−$119.49K
18,237
$387.54K
Li Yang
Exec. Vice President, Research
$89.65K (3)
−$89.65K
18,882
$401.24K
+122.1%
BLUTT MITCHELL J MD
10% owner
(5)
(4)
$0.00
6,750,500
$143.45M
−17.7%
Consonance Life Sciences
Former 10% Holder
(2)
$0.00
2,319,000
$49.28M
−12.3%
Livingston Kevin Harold
Former Chief Financial Officer
(2)
$0.00
1,885,000
$40.06M
−14.7%
Soffer Benny
FORMER DIRECTOR
(2)
$0.00
1,885,000
$40.06M
−14.7%
Vanhove Geertrui
Chief Medical Officer
32,412
$688.76K
+41.9%
Jarrett Jennifer
Former Director
30,000
$637.50K
Haqq Christopher
Former Director
30,000
$637.50K
Santel Donald J
Former Director
30,000
$637.50K
Yeh Wen-Chen
Chief Scientific Officer
27,216
$578.34K
Maleki Andrew Pedrum
Chief Financial Officer
607
$12.90K

No percentages here. This company's share count has moved by a factor of 3.6 over the window, from 3,249,798 to 11,753,558 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 17
Shares from compensation/vesting 18,335,678
Sales filed before the plan box existed 4
History held since 25 Nov 2020